Archive
Back to homepage
ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, Furthering its Ambition to Become the Global Leader in Regenerative Therapies
NANJING, China, Jan. 26, 2023 /PRNewswire/ — As the tissue engineering and regenerative treatment industry has shown tremendous potential in clinical practices in recent years worldwide, China’s blue ocean market welcomes the first wave of acquisitions. ReLive Biotechnologies, Ltd. (“ReLive”
Read More
SMMT : 2022 UK car production down but electric vehicle output surges to new record
Annual UK car production falls -9.8% to 775,014 units in 2022 as global chip shortages and structural changes depress output. Record levels of electrified vehicle production with almost a third of all cars made fully electric or hybrid – worth
Read More
MedAlliance leads US Sirolimus DEB race: First US Patient enrolled into SELUTION SLR Coronary Sirolimus DEB Study
GENEVA, Jan. 26, 2023 /PRNewswire/ — The first US patient has been enrolled at MedStar Washington Hospital Center in the SELUTION4ISR study evaluating SELUTION SLR™ to support FDA approval. This milestone follows Investigational Device Exemption (IDE) approval in the US in
Read More